Craniomaxillofacial Implants for Medical Sector Market Risk, Driving Force with Top Players Stryker, Johnson & Johnson, Zimmer Biomet Holdings,Medtronic

Craniomaxillofacial is a special branch of orthopedic surgery, which focuses on all the aspects of facial and skull disorders. The craniomaxillofacial implant surgery is carried out to treat a severe injury of facial and cranial bones, where the implants are temporarily or permanently placed in the body. Traumas, accidents, and genetic defects lead to craniomaxillofacial deformities. Craniomaxillofacial implants surgery is also carried out to correct abnormalities and deformities caused by diseases, such as Crouzon’s disease and Apert’s Syndrome. Initially, the emphasis was just on keeping absolute stability of the bones, without much attention on free movements. However, owing to advancements in technology and implant materials such as biocompatible titanium implants, resorbable plates, screws, and bone grafts, have increased the scope for maintaining stability as well as functionality of the joints, allowing for ease of treatments related to craniomaxillofacial deformities. Furthermore, lack of other alternatives for facial surgeries is expected to favor the craniomaxillofacial implants market. Birth defects such as cleft palate and anotia are also treated through craniomaxillofacial surgeries. According to the Centers for Disease Control and Prevention in the U.S., around 2,650 babies are recorded to be born with a cleft palate, every year. Improvement in implant materials and minimal invasiveness of this type of surgery is increasing its demand among the populace.

Few growth restraining factors are the high costs associated with craniomaxillofacial surgeries and low availability of skilled surgeons.

The global craniomaxillofacial implant market was valued at US$ 1,907.9 million in 2016 and is expected to witness a robust CAGR of 6.2% over the forecast period (2017-2025).

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/773

North America was the dominant region in 2016 and accounted the largest share in the global craniomaxillofacial implants market followed by Europe. The major factor for the dominance of North America in craniomaxillofacial implants market is the high presence of skilled surgeons in the region. According to Center for Disease Control and Prevention in the U.S., around 2 million high school athletes are reported with injuries annually, in which head injuries accounted for 14% each year. Asia Pacific is expected to witness the largest growth rate in the craniomaxillofacial implants market during the forecast period. Factors such as rising expenditure on healthcare by the population and increasing rate of sports-related injuries will augment growth of craniomaxillofacial implants market. Furthermore, old people are prone to higher risk injuries due to their weak skeletal system, and an increasing geriatric pupation will boost the growth of craniomaxillofacial implants market in the near future. According to National Institute on Aging, 524 million people were recorded to be 65 years of age and above in the U.S., accounting for 8% of the world's population in 2010. Also estimates from the same source, by 2050 the population of U.S. will be around 1.5 billion, three times more than in 2010, representing 16% of the world's population.

Improved craniomaxillofacial implant materials and advent of new technologies associated with surgeries are expected to drive the craniomaxillofacial implants market

Patient specific implants, 3D implants, growing demand for bioresorbable materials, and growing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Whereas, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures, combined with refinements in surgical equipment such as resorbable plating and distractors, have improved surgical outcomes, while minimizing morbidity. The development of bone graft substitutes with the help of gene therapy and nanotechnology is also expected to drive the craniomaxillofacial implants market.

Some major players operating in the craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgicssal USA.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/773

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.